Skip to content
★ Sign in to follow
MM

Matthew M. Gosling

Depomed Inc
Total declarations
30
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (16 ops.)
€2.6M

Latest filing published 15 May 2018 for DEPOMED INC, €117k.

Filing timeline

BuySale
Matthew M. Gosling

Insider track record

Disclosed buys
0
Disclosed sells
16
Signal history

Matthew M. Gosling: trading record in brief

Matthew M. Gosling is a declared insider of Depomed Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 11 August 2009 to 11 May 2018, the count stands at 30 filings.

No open-market purchase appears, only 16 sales worth €2.6M. The rest of the record consists of 6 share grants and 8 option exercises. In 2018 alone, the filings show no purchases and 2 sales.

The record was last updated on 15 May 2018 with an open-market sale (€117k) in Depomed Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Matthew M. Gosling

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations27 total
  • ▼
    SVP, General CounselExecutivesDepomed Inc
    139,095 USD12SEC
    19,674 shares@ US$7.078.5% of flowCommon StockSEC:0001179110-18-006817:0
  • ◆
    SVP, General CounselExecutivesDepomed Inc
    68,048 USD11SEC
    10,326 shares@ US$6.594.0% of flowCommon StockSEC:0001179110-18-005347:0
  • ▼
    SVP, General CounselExecutivesDepomed Inc
    299,515 USD13SEC
    45,519 shares@ US$6.5817.6% of flowCommon StockSEC:0001179110-18-004009:0
  • ◆
    SVP, General CounselExecutivesDepomed Inc
    98,210 USD12SEC
    13,813 shares@ US$7.116.0% of flowCommon StockSEC:0001179110-17-014988:0
  • ▼
    SVP, General CounselExecutivesDepomed Inc
    673,240 USD28SEC
    59,212 shares@ US$11.3745.2% of flowCommon StockSEC:0001179110-17-007224:0
  • ◆
    SVP, General CounselExecutivesDepomed Inc
    11,797 USD11SEC
    940 shares@ US$12.550.8% of flowCommon StockSEC:0001179110-17-005724:0
  • ◆
    SVP, General CounselExecutivesDepomed Inc
    244,897 USD13SEC
    13,202 shares@ US$18.5516.9% of flowCommon StockSEC:0001179110-16-032494:0
  • ◆
    SVP, General CounselExecutivesDepomed Inc
    13,517 USD11SEC
    940 shares@ US$14.380.9% of flowCommon StockSEC:0001179110-16-022839:0
  • ◆
    SVP, General CounselExecutivesDepomed Inc
    227,639 USD0SEC
    11,981 shares@ US$19.00Common StockSEC:0001179110-15-015768:0
  • ▼
    Senior VP, General CounselExecutivesDepomed Inc
    139,781 USD0SEC
    8,819 shares@ US$15.85Common StockSEC:0001179110-14-017517:0
  • ◇
    Senior VP, General CounselExecutivesDepomed Inc
    438,070 USD0SEC
    71,000 shares@ US$6.17Common StockSEC:0001179110-14-016923:0
  • ▼
    Senior VP, General CounselExecutivesDepomed Inc
    1M USD0SEC
    71,000 shares@ US$15.36Common StockSEC:0001179110-14-016923:1
  • ◇
    Senior VP, General CounselExecutivesDepomed Inc
    24,680 USD0SEC
    4,000 shares@ US$6.17Common StockSEC:0001179110-14-008131:0
  • ◇
    Senior VP, General CounselExecutivesDepomed Inc
    67,594 USD0SEC
    21,875 shares@ US$3.09Common StockSEC:0001179110-14-005241:0
  • ▼
    Senior VP, General CounselExecutivesDepomed Inc
    322,438 USD0SEC
    21,875 shares@ US$14.74Common StockSEC:0001179110-14-005241:1
  • ▼
    Senior VP, General CounselExecutivesDepomed Inc
    47,813 USD0SEC
    5,692 shares@ US$8.40Common StockSEC:0001179110-13-017422:0
  • ◇
    Senior VP, General CounselExecutivesDepomed Inc
    148,706 USD0SEC
    48,125 shares@ US$3.09Common StockSEC:0001179110-12-017722:0
  • ▼
    Senior VP, General CounselExecutivesDepomed Inc
    383,700 USD0SEC
    65,702 shares@ US$5.84Common StockSEC:0001179110-12-017722:1
  • ▼
    Senior VP, General CounselExecutivesDepomed Inc
    15,167 USD0SEC
    2,615 shares@ US$5.80Common StockSEC:0001179110-12-017083:0
  • ▼
    VP, General CounselExecutivesDepomed Inc
    24,656 USD0SEC
    6,700 shares@ US$3.68Common StockSEC:0001179110-09-012077:0
  • ▼
    VP, General CounselExecutivesDepomed Inc
    366 USD0SEC
    100 shares@ US$3.66Common StockSEC:0001179110-09-012077:1
  • ▼
    VP, General CounselExecutivesDepomed Inc
    21,563 USD0SEC
    5,924 shares@ US$3.64Common StockSEC:0001179110-09-012077:2
  • ◇
    VP, General CounselExecutivesDepomed Inc
    4,950 USD0SEC
    2,500 shares@ US$1.98Common StockSEC:0001179110-09-012077:3
  • ▼
    VP, General CounselExecutivesDepomed Inc
    9,175 USD0SEC
    2,500 shares@ US$3.67Common StockSEC:0001179110-09-012077:4
  • ◇
    VP, General CounselExecutivesDepomed Inc
    9,900 USD0SEC
    5,000 shares@ US$1.98Common StockSEC:0001179110-09-012077:5

25 of 27 declarations